
Atrasorb PHARMA
Negligible dust release and semi-spherical pellets that do not create preferential channels inside the canister.
Developed after extensive research and rigorous quality testing, Atrasorb Pharma® has negligible dust release and semi-spherical pellets which, once packed into the canister, do not create preferential channels — ensuring homogeneous CO₂ absorption.
Through dedicated processes, equipment and technology, Atrasorb Pharma® reached a high level of CO₂ absorption compared with its main competitors, which means savings thanks to greater yield.
Another highlight is the moisture content between 16% and 18%, which helps humidify and warm the air inhaled during anesthesia.
Documents: FDS-001 / IS-001 · Registration: 81045870003


